Open0.241 | Close- |
Vol / Avg.999.722K / 1.364M | Mkt Cap22.684M |
Day Range0.241 - 0.290 | 52 Wk Range0.221 - 1.530 |
NRX Pharmaceuticals Stock (NASDAQ: NRXP) stock price, news, charts, stock research, profile.
Open0.241 | Close- |
Vol / Avg.999.722K / 1.364M | Mkt Cap22.684M |
Day Range0.241 - 0.290 | 52 Wk Range0.221 - 1.530 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.140 | -0.120 | 0.0200 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-05-25 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | BuyBuy | Maintains | - | 2.00 |
2023-02-02 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Maintains | - | 2.00 |
2022-11-09 | Ascendiant Capital | Edward Woo | Initiates Coverage On | Buy | Announces | - | 4.00 |
2022-06-30 | HC Wainwright & Co. | Vernon Bernardino | Initiates Coverage On | Buy | Announces | - | 2.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
NRXP | NRX Pharmaceuticals | 8.78% | 22.7M |
CING | Cingulate | 3.99% | 12.3M |
CPIX | Cumberland | 1.65% | 27.5M |
COCP | Cocrystal Pharma | -1.02% | 19.7M |
ONTX | Onconova Therapeutics | -0.74% | 15.1M |
You can purchase shares of NRX Pharmaceuticals (NASDAQ: NRXP) through any online brokerage.
Other companies in NRX Pharmaceuticals’s space includes: Cingulate (NASDAQ:CING), Cumberland (NASDAQ:CPIX), Cocrystal Pharma (NASDAQ:COCP), Onconova Therapeutics (NASDAQ:ONTX) and CalciMedica (NASDAQ:CALC).
The latest price target for NRX Pharmaceuticals (NASDAQ: NRXP) was reported by HC Wainwright & Co. on Thursday, May 25, 2023. The analyst firm set a price target for 2.00 expecting NRXP to rise to within 12 months (a possible 633.94% upside). 3 analyst firms have reported ratings in the last year.
The stock price for NRX Pharmaceuticals (NASDAQ: NRXP) is $0.2725 last updated Today at September 28, 2023 at 7:52 PM UTC.
There is no dividend information for NRX Pharmaceuticals.
NRX Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for NRX Pharmaceuticals.
NRX Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
NRX Pharmaceuticals Stock (NASDAQ: NRXP) stock price, news, charts, stock research, profile.
Open0.241 | Close- |
Vol / Avg.999.722K / 1.364M | Mkt Cap22.684M |
Day Range0.241 - 0.290 | 52 Wk Range0.221 - 1.530 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.140 | -0.120 | 0.0200 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-05-25 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | BuyBuy | Maintains | - | 2.00 |
2023-02-02 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Maintains | - | 2.00 |
2022-11-09 | Ascendiant Capital | Edward Woo | Initiates Coverage On | Buy | Announces | - | 4.00 |
2022-06-30 | HC Wainwright & Co. | Vernon Bernardino | Initiates Coverage On | Buy | Announces | - | 2.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
NRXP | NRX Pharmaceuticals | 8.78% | 22.7M |
CING | Cingulate | 3.99% | 12.3M |
CPIX | Cumberland | 1.65% | 27.5M |
COCP | Cocrystal Pharma | -1.02% | 19.7M |
ONTX | Onconova Therapeutics | -0.74% | 15.1M |
You can purchase shares of NRX Pharmaceuticals (NASDAQ: NRXP) through any online brokerage.
Other companies in NRX Pharmaceuticals’s space includes: Cingulate (NASDAQ:CING), Cumberland (NASDAQ:CPIX), Cocrystal Pharma (NASDAQ:COCP), Onconova Therapeutics (NASDAQ:ONTX) and CalciMedica (NASDAQ:CALC).
The latest price target for NRX Pharmaceuticals (NASDAQ: NRXP) was reported by HC Wainwright & Co. on Thursday, May 25, 2023. The analyst firm set a price target for 2.00 expecting NRXP to rise to within 12 months (a possible 633.94% upside). 3 analyst firms have reported ratings in the last year.
The stock price for NRX Pharmaceuticals (NASDAQ: NRXP) is $0.2725 last updated Today at September 28, 2023 at 7:52 PM UTC.
There is no dividend information for NRX Pharmaceuticals.
NRX Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for NRX Pharmaceuticals.
NRX Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
NRX Pharmaceuticals Stock (NASDAQ: NRXP) stock price, news, charts, stock research, profile.
Open0.241 | Close- |
Vol / Avg.999.722K / 1.364M | Mkt Cap22.684M |
Day Range0.241 - 0.290 | 52 Wk Range0.221 - 1.530 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.140 | -0.120 | 0.0200 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-05-25 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | BuyBuy | Maintains | - | 2.00 |
2023-02-02 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Maintains | - | 2.00 |
2022-11-09 | Ascendiant Capital | Edward Woo | Initiates Coverage On | Buy | Announces | - | 4.00 |
2022-06-30 | HC Wainwright & Co. | Vernon Bernardino | Initiates Coverage On | Buy | Announces | - | 2.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
NRXP | NRX Pharmaceuticals | 8.78% | 22.7M |
CING | Cingulate | 3.99% | 12.3M |
CPIX | Cumberland | 1.65% | 27.5M |
COCP | Cocrystal Pharma | -1.02% | 19.7M |
ONTX | Onconova Therapeutics | -0.74% | 15.1M |
You can purchase shares of NRX Pharmaceuticals (NASDAQ: NRXP) through any online brokerage.
Other companies in NRX Pharmaceuticals’s space includes: Cingulate (NASDAQ:CING), Cumberland (NASDAQ:CPIX), Cocrystal Pharma (NASDAQ:COCP), Onconova Therapeutics (NASDAQ:ONTX) and CalciMedica (NASDAQ:CALC).
The latest price target for NRX Pharmaceuticals (NASDAQ: NRXP) was reported by HC Wainwright & Co. on Thursday, May 25, 2023. The analyst firm set a price target for 2.00 expecting NRXP to rise to within 12 months (a possible 633.94% upside). 3 analyst firms have reported ratings in the last year.
The stock price for NRX Pharmaceuticals (NASDAQ: NRXP) is $0.2725 last updated Today at September 28, 2023 at 7:52 PM UTC.
There is no dividend information for NRX Pharmaceuticals.
NRX Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for NRX Pharmaceuticals.
NRX Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
NRX Pharmaceuticals Stock (NASDAQ: NRXP) stock price, news, charts, stock research, profile.
Open0.241 | Close- |
Vol / Avg.999.722K / 1.364M | Mkt Cap22.684M |
Day Range0.241 - 0.290 | 52 Wk Range0.221 - 1.530 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.140 | -0.120 | 0.0200 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-05-25 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | BuyBuy | Maintains | - | 2.00 |
2023-02-02 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Maintains | - | 2.00 |
2022-11-09 | Ascendiant Capital | Edward Woo | Initiates Coverage On | Buy | Announces | - | 4.00 |
2022-06-30 | HC Wainwright & Co. | Vernon Bernardino | Initiates Coverage On | Buy | Announces | - | 2.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
NRXP | NRX Pharmaceuticals | 8.78% | 22.7M |
CING | Cingulate | 3.99% | 12.3M |
CPIX | Cumberland | 1.65% | 27.5M |
COCP | Cocrystal Pharma | -1.02% | 19.7M |
ONTX | Onconova Therapeutics | -0.74% | 15.1M |
You can purchase shares of NRX Pharmaceuticals (NASDAQ: NRXP) through any online brokerage.
Other companies in NRX Pharmaceuticals’s space includes: Cingulate (NASDAQ:CING), Cumberland (NASDAQ:CPIX), Cocrystal Pharma (NASDAQ:COCP), Onconova Therapeutics (NASDAQ:ONTX) and CalciMedica (NASDAQ:CALC).
The latest price target for NRX Pharmaceuticals (NASDAQ: NRXP) was reported by HC Wainwright & Co. on Thursday, May 25, 2023. The analyst firm set a price target for 2.00 expecting NRXP to rise to within 12 months (a possible 633.94% upside). 3 analyst firms have reported ratings in the last year.
The stock price for NRX Pharmaceuticals (NASDAQ: NRXP) is $0.2725 last updated Today at September 28, 2023 at 7:52 PM UTC.
There is no dividend information for NRX Pharmaceuticals.
NRX Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for NRX Pharmaceuticals.
NRX Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
NRX Pharmaceuticals Stock (NASDAQ: NRXP) stock price, news, charts, stock research, profile.
Open0.241 | Close- |
Vol / Avg.999.722K / 1.364M | Mkt Cap22.684M |
Day Range0.241 - 0.290 | 52 Wk Range0.221 - 1.530 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.140 | -0.120 | 0.0200 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-05-25 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | BuyBuy | Maintains | - | 2.00 |
2023-02-02 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Maintains | - | 2.00 |
2022-11-09 | Ascendiant Capital | Edward Woo | Initiates Coverage On | Buy | Announces | - | 4.00 |
2022-06-30 | HC Wainwright & Co. | Vernon Bernardino | Initiates Coverage On | Buy | Announces | - | 2.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
NRXP | NRX Pharmaceuticals | 8.78% | 22.7M |
CING | Cingulate | 3.99% | 12.3M |
CPIX | Cumberland | 1.65% | 27.5M |
COCP | Cocrystal Pharma | -1.02% | 19.7M |
ONTX | Onconova Therapeutics | -0.74% | 15.1M |
You can purchase shares of NRX Pharmaceuticals (NASDAQ: NRXP) through any online brokerage.
Other companies in NRX Pharmaceuticals’s space includes: Cingulate (NASDAQ:CING), Cumberland (NASDAQ:CPIX), Cocrystal Pharma (NASDAQ:COCP), Onconova Therapeutics (NASDAQ:ONTX) and CalciMedica (NASDAQ:CALC).
The latest price target for NRX Pharmaceuticals (NASDAQ: NRXP) was reported by HC Wainwright & Co. on Thursday, May 25, 2023. The analyst firm set a price target for 2.00 expecting NRXP to rise to within 12 months (a possible 633.94% upside). 3 analyst firms have reported ratings in the last year.
The stock price for NRX Pharmaceuticals (NASDAQ: NRXP) is $0.2725 last updated Today at September 28, 2023 at 7:52 PM UTC.
There is no dividend information for NRX Pharmaceuticals.
NRX Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for NRX Pharmaceuticals.
NRX Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
NRX Pharmaceuticals Stock (NASDAQ: NRXP) stock price, news, charts, stock research, profile.
Open0.241 | Close- |
Vol / Avg.999.722K / 1.364M | Mkt Cap22.684M |
Day Range0.241 - 0.290 | 52 Wk Range0.221 - 1.530 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.140 | -0.120 | 0.0200 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-05-25 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | BuyBuy | Maintains | - | 2.00 |
2023-02-02 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Maintains | - | 2.00 |
2022-11-09 | Ascendiant Capital | Edward Woo | Initiates Coverage On | Buy | Announces | - | 4.00 |
2022-06-30 | HC Wainwright & Co. | Vernon Bernardino | Initiates Coverage On | Buy | Announces | - | 2.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
NRXP | NRX Pharmaceuticals | 8.78% | 22.7M |
CING | Cingulate | 3.99% | 12.3M |
CPIX | Cumberland | 1.65% | 27.5M |
COCP | Cocrystal Pharma | -1.02% | 19.7M |
ONTX | Onconova Therapeutics | -0.74% | 15.1M |
You can purchase shares of NRX Pharmaceuticals (NASDAQ: NRXP) through any online brokerage.
Other companies in NRX Pharmaceuticals’s space includes: Cingulate (NASDAQ:CING), Cumberland (NASDAQ:CPIX), Cocrystal Pharma (NASDAQ:COCP), Onconova Therapeutics (NASDAQ:ONTX) and CalciMedica (NASDAQ:CALC).
The latest price target for NRX Pharmaceuticals (NASDAQ: NRXP) was reported by HC Wainwright & Co. on Thursday, May 25, 2023. The analyst firm set a price target for 2.00 expecting NRXP to rise to within 12 months (a possible 633.94% upside). 3 analyst firms have reported ratings in the last year.
The stock price for NRX Pharmaceuticals (NASDAQ: NRXP) is $0.2725 last updated Today at September 28, 2023 at 7:52 PM UTC.
There is no dividend information for NRX Pharmaceuticals.
NRX Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for NRX Pharmaceuticals.
NRX Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
NRX Pharmaceuticals Stock (NASDAQ: NRXP) stock price, news, charts, stock research, profile.
Open0.241 | Close- |
Vol / Avg.999.722K / 1.364M | Mkt Cap22.684M |
Day Range0.241 - 0.290 | 52 Wk Range0.221 - 1.530 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.140 | -0.120 | 0.0200 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-05-25 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | BuyBuy | Maintains | - | 2.00 |
2023-02-02 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Maintains | - | 2.00 |
2022-11-09 | Ascendiant Capital | Edward Woo | Initiates Coverage On | Buy | Announces | - | 4.00 |
2022-06-30 | HC Wainwright & Co. | Vernon Bernardino | Initiates Coverage On | Buy | Announces | - | 2.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
NRXP | NRX Pharmaceuticals | 8.78% | 22.7M |
CING | Cingulate | 3.99% | 12.3M |
CPIX | Cumberland | 1.65% | 27.5M |
COCP | Cocrystal Pharma | -1.02% | 19.7M |
ONTX | Onconova Therapeutics | -0.74% | 15.1M |
You can purchase shares of NRX Pharmaceuticals (NASDAQ: NRXP) through any online brokerage.
Other companies in NRX Pharmaceuticals’s space includes: Cingulate (NASDAQ:CING), Cumberland (NASDAQ:CPIX), Cocrystal Pharma (NASDAQ:COCP), Onconova Therapeutics (NASDAQ:ONTX) and CalciMedica (NASDAQ:CALC).
The latest price target for NRX Pharmaceuticals (NASDAQ: NRXP) was reported by HC Wainwright & Co. on Thursday, May 25, 2023. The analyst firm set a price target for 2.00 expecting NRXP to rise to within 12 months (a possible 633.94% upside). 3 analyst firms have reported ratings in the last year.
The stock price for NRX Pharmaceuticals (NASDAQ: NRXP) is $0.2725 last updated Today at September 28, 2023 at 7:52 PM UTC.
There is no dividend information for NRX Pharmaceuticals.
NRX Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for NRX Pharmaceuticals.
NRX Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
NRX Pharmaceuticals Stock (NASDAQ: NRXP) stock price, news, charts, stock research, profile.
Open0.241 | Close- |
Vol / Avg.999.722K / 1.364M | Mkt Cap22.684M |
Day Range0.241 - 0.290 | 52 Wk Range0.221 - 1.530 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.140 | -0.120 | 0.0200 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-05-25 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | BuyBuy | Maintains | - | 2.00 |
2023-02-02 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Maintains | - | 2.00 |
2022-11-09 | Ascendiant Capital | Edward Woo | Initiates Coverage On | Buy | Announces | - | 4.00 |
2022-06-30 | HC Wainwright & Co. | Vernon Bernardino | Initiates Coverage On | Buy | Announces | - | 2.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
NRXP | NRX Pharmaceuticals | 8.78% | 22.7M |
CING | Cingulate | 3.99% | 12.3M |
CPIX | Cumberland | 1.65% | 27.5M |
COCP | Cocrystal Pharma | -1.02% | 19.7M |
ONTX | Onconova Therapeutics | -0.74% | 15.1M |
You can purchase shares of NRX Pharmaceuticals (NASDAQ: NRXP) through any online brokerage.
Other companies in NRX Pharmaceuticals’s space includes: Cingulate (NASDAQ:CING), Cumberland (NASDAQ:CPIX), Cocrystal Pharma (NASDAQ:COCP), Onconova Therapeutics (NASDAQ:ONTX) and CalciMedica (NASDAQ:CALC).
The latest price target for NRX Pharmaceuticals (NASDAQ: NRXP) was reported by HC Wainwright & Co. on Thursday, May 25, 2023. The analyst firm set a price target for 2.00 expecting NRXP to rise to within 12 months (a possible 633.94% upside). 3 analyst firms have reported ratings in the last year.
The stock price for NRX Pharmaceuticals (NASDAQ: NRXP) is $0.2725 last updated Today at September 28, 2023 at 7:52 PM UTC.
There is no dividend information for NRX Pharmaceuticals.
NRX Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for NRX Pharmaceuticals.
NRX Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
NRX Pharmaceuticals Stock (NASDAQ: NRXP) stock price, news, charts, stock research, profile.
Open0.241 | Close- |
Vol / Avg.999.722K / 1.364M | Mkt Cap22.684M |
Day Range0.241 - 0.290 | 52 Wk Range0.221 - 1.530 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.140 | -0.120 | 0.0200 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-05-25 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | BuyBuy | Maintains | - | 2.00 |
2023-02-02 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Maintains | - | 2.00 |
2022-11-09 | Ascendiant Capital | Edward Woo | Initiates Coverage On | Buy | Announces | - | 4.00 |
2022-06-30 | HC Wainwright & Co. | Vernon Bernardino | Initiates Coverage On | Buy | Announces | - | 2.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
NRXP | NRX Pharmaceuticals | 8.78% | 22.7M |
CING | Cingulate | 3.99% | 12.3M |
CPIX | Cumberland | 1.65% | 27.5M |
COCP | Cocrystal Pharma | -1.02% | 19.7M |
ONTX | Onconova Therapeutics | -0.74% | 15.1M |
You can purchase shares of NRX Pharmaceuticals (NASDAQ: NRXP) through any online brokerage.
Other companies in NRX Pharmaceuticals’s space includes: Cingulate (NASDAQ:CING), Cumberland (NASDAQ:CPIX), Cocrystal Pharma (NASDAQ:COCP), Onconova Therapeutics (NASDAQ:ONTX) and CalciMedica (NASDAQ:CALC).
The latest price target for NRX Pharmaceuticals (NASDAQ: NRXP) was reported by HC Wainwright & Co. on Thursday, May 25, 2023. The analyst firm set a price target for 2.00 expecting NRXP to rise to within 12 months (a possible 633.94% upside). 3 analyst firms have reported ratings in the last year.
The stock price for NRX Pharmaceuticals (NASDAQ: NRXP) is $0.2725 last updated Today at September 28, 2023 at 7:52 PM UTC.
There is no dividend information for NRX Pharmaceuticals.
NRX Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for NRX Pharmaceuticals.
NRX Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.